Drug cost-effect aspects of structum administration in osteoarthrosis

Terapevticheskii Arkhiv

Volumn 73, Issue 11, 2001, Pages 90-92

  Alekseeva, L I ^a   Mednikov, B L ^a   Piyavsky, S A ^a   Nasonova, V A ^a   Soldatov, D G ^a  

^a NONE

Author keywords

Chondroitin sulphate; Cost effect efficacy; Drug cost effect analysis; Osteoarthrosis; Structum

Indexed keywords

CHONDROITIN SULFATE;

ARTICLE; CLINICAL TRIAL; COST; ECONOMICS; FEMALE; HIP; HUMAN; KNEE; MALE; MULTICENTER STUDY; OSTEOARTHRITIS;

CHONDROITIN SULFATES; COSTS AND COST ANALYSIS; FEMALE; HIP JOINT; HUMANS; KNEE JOINT; MALE; OSTEOARTHRITIS;

EID: 0035748839     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Simon L. S. Osteoarthritis: a review. Clin. Cornerstone 1999; 2: 26-37.
2. March L. M., Bachmeier C. J. Economics of osteoarthritis: a global perspective. Baillieres Clin. Rheumatol. 1998; 11: 817-834.
3. Rothfuss J., Mau W., Zeidler H., Brenner M. N. Socioeconomic evaluation of rheumatoid arthritis and osteoarthritis : a literature review. Semin. Arthr. Rheum. 1997; 26: 771-779.
4. Tugwell P. Economic evaluation of the management of pain in osteoarthritis. Drugs 1996; 52 (suppl. 3): 48-58.
5. Avouac B., Maheu E., Salliere D. et al. Social impact of osteoarthritis. Risk/benefit - cost-effectiveness ratio of osteoarthritis treatment. Rev. Rhum. Mal Osteoarthic. 1990; 57: 37S-43S.
6. Rutten-van Molker M. P. M. H. Principles of economic evaluation in rheumatology. Rheumatol. in Europe 1998; 27: 7-10.